We are live on ! Find out more
BIOTW

Biotech Acquisition Company Warrant
BIOTW

Delisted

BIOTW was delisted on the 2nd of February, 2023.

Back to rankings

52 hedge funds and large institutions have $5.06M invested in Biotech Acquisition Company Warrant in 2022 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 9 increasing their positions, 11 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

7% less funds holding

Funds holding: 56 → 52 (-4)

18% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 11

40% less capital invested

Capital invested by funds: $8.44M → $5.06M (-$3.38M)

44% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 9

Holders
52
Holders Change
-4
Holders Change %
-7.14%
% of All Funds
0.82%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
9
Reduced
11
Closed
9
Calls
$5.74M
Puts
–
Net Calls
+$5.74M
Net Calls Change
-$37K

Top Buyers

Rank Fund Capital Flow
1
HIM
HGC Investment Management
Ontario, Canada
+$212K
2
KSCM
Kamunting Street Capital Management
Florida
+$50.7K
3
QGA
Q Global Advisors
Texas
+$43.2K
4
SCM
Shaolin Capital Management
Florida
+$14.9K
5
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
+$7.97K

Top Sellers

Rank Fund Capital Flow
1
RA
Ramius Advisors
New York
-$299K
2
Blackstone Inc
Blackstone Inc
New York
-$165K
3
FTCM
Fir Tree Capital Management
New York
-$82K
4
AGM
Alpine Global Management
New York
-$67K
5
PSAMP
P. Schoenfeld Asset Management (PSAM)
New York
-$66K
Name Holding Trade Value Shares
Change 		Change in
Stake
CH
26
CVI Holdings
Delaware
$24K – – –
SCM
27
Shaolin Capital Management
Florida
$24K +$14.9K +46,589 +87%
CCM
28
Context Capital Management
California
$23K – – –
WA
29
Whitebox Advisors
Minnesota
$14K -$1.59K -5,000 -8%
Jane Street
30
Jane Street
New York
$13K +$119 +373 +0.7%
CCA
31
Castle Creek Arbitrage
Colorado
$12K – – –
CP
32
Centerbridge Partners
New York
$12K – – –
Walleye Capital
33
Walleye Capital
New York
$11K -$802 -2,515 -5%
Walleye Trading
34
Walleye Trading
New York
$10K – – –
State of Wisconsin Investment Board
35
State of Wisconsin Investment Board
Wisconsin
$9K – – –
CAC
36
Cowen and Company
New York
$8K -$13.9K -43,472 -56%
ICMH
37
Integrity Capital Management (HK)
Hong Kong
$8K -$13.1K -41,005 -55%
WAM
38
Wolverine Asset Management
Illinois
$8K – – –
PFM
39
Privium Fund Management
Netherlands
$7K – – –
AA
40
AQR Arbitrage
Connecticut
$6K – – –
YCM
41
Yakira Capital Management
Connecticut
$6K – – –
COPPSERS
42
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$6K +$7.97K +25,000 New
HF
43
HRT Financial
New York
$5K +$829 +2,600 +13%
Susquehanna International Group
44
Susquehanna International Group
Pennsylvania
$4K -$3.29K -10,331 -40%
AA
45
Ancora Advisors
Ohio
$4K +$3.19K +10,000 +187%
CS
46
Clear Street
New York
$4K +$5.05K +15,851 New
BCM
47
Basso Capital Management
Connecticut
$3K – – –
OAC
48
OMERS Administration Corp
Ontario, Canada
$3K – – –
BCM
49
BCK Capital Management
Connecticut
$3K +$4.33K +13,573 New
Bank of America
50
Bank of America
North Carolina
$2K – – –
1
2
3

BIOTW Hedge Fund Activity: Q1 2022 in Review

52 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Biotech Acquisition Company Warrant (BIOTW) for Q1 2022, worth a combined $5.06M — down 40% from $8.44M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of BIOTW and 5 opened new positions — a net loss of 4 holders — while 11 trimmed existing stakes and 9 added.

The largest buyer was HGC Investment Management, adding an estimated $212K. The largest seller was Ramius Advisors, exiting entirely with an estimated $299K sold.

  • 52 institutional investors held Biotech Acquisition Company Warrant (BIOTW) as of Q1 2022, down from 56 in Q4 2021.
  • Funds reported $5.06M of Biotech Acquisition Company Warrant stock for Q1 2022, down 40% quarter-over-quarter.
  • 5 funds opened new Biotech Acquisition Company Warrant positions in Q1 2022 and 9 closed out, a net change of -4 holders.
  • The largest Biotech Acquisition Company Warrant buyer in Q1 2022 was HGC Investment Management, an estimated $212K added.
  • The largest Biotech Acquisition Company Warrant seller in Q1 2022 was Ramius Advisors, an estimated $299K sold.

Based on aggregated 13F filings for Q1 2022.